Abiopharma

Peters Malte 🟢 acquired 2.0M shares (1 derivative) of Tango Therapeutics, Inc. (TNGX) at $11.06 ($18.2M) Transaction Date: Jan 08, 2026 | Filing ID: 009663

Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

New Form SC TO-T - DYNAVAX TECHNOLOGIES CORP Filed: 2026-01-12 AccNo: 0001193125-26-009651 Size: 2 MB

(99% Neutral) Ideaya Biosciences Inc (IDYA) Announces Clinical Development Update

New Form 5 - Innovative Eyewear Inc Filed: 2026-01-12 AccNo: 0001829126-26-000202 Size: 12 KB

(10% Negative) Ideaya Biosciences Inc (IDYA) Announces Delay in population Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) Kura Oncology Inc (KURA) Announces Enrollment Update for approved Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Positive) Veracyte Inc (VCYT) Reports Q1 2026 Financial Results

(75% Positive) Guardant Health Inc (GH) Reports Q1 2026 Financial Results

(99% Neutral) Jaguar Health Inc. (JAGX) Announces Business Combination

(99% Neutral) Thermo Fisher Scientific Inc (TMO) Announces Executive Changes

New Form EFFECT - Cidara Therapeutics, Inc. Filed: 2026-01-09 AccNo: 9999999995-26-000124 Size: 1 KB

New Form EFFECT - Cidara Therapeutics, Inc. Filed: 2026-01-09 AccNo: 9999999995-26-000126 Size: 1 KB

New Form EFFECT - Century Therapeutics, Inc. Filed: 2026-01-09 AccNo: 9999999995-26-000127 Size: 1 KB

New Form EFFECT - Aspira Women's Health Inc. Filed: 2026-01-09 AccNo: 9999999995-26-000142 Size: 2 KB